Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Rheumatology 3, 694–695 (1 December 2007) | doi:10.1038/ncprheum0650
Proton-pump inhibitors as a protective treatment for high-risk patients receiving treatment with NSAIDs
Abstract
Vonkeman HE et al. (2007) Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case–control study. Arthritis Res Ther 9: R52 Synopsis Background Gastrointestinal complications are the main concern of NSAID treatment in patients with rheumatic diseases.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
